Centene Corporation CNC
Verdict: Sell. Fair value $73.51 against a price of $44.68 on 6 Jan 2026, 65% above the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Operating Cash Flow plummeted 98% from $8.05B in 2023 to just $0.15B in 2024, while Net Income.... The massive $3.16B divergence between Net Income ($3.31B) and OCF ($0.15B) in 2024 is a major red....
Main risks
- Negative Free Cash Flow in 2024: The most recent full year shows FCF of -$0.49B, a sharp reversal from prior years and a major red flag for cash generation ability, even though TTM FCF is positive.
- High Leverage: The estimated Net Debt to EBITDA ratio is high at approximately 4.8x. This level of leverage, combined with thin margins, increases financial risk.
- Decelerating Revenue Growth: While still positive, year-over-year revenue growth has slowed from 14.7% (2022) to 5.9% (2024), indicating potential market saturation or increased competition.
- Operating Cash Flow plummeted 98% from $8.05B in 2023 to just $0.15B in 2024, while Net Income...
- The massive $3.16B divergence between Net Income ($3.31B) and OCF ($0.15B) in 2024 is a major red...
- Intense competitive environment